{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:21:26Z","timestamp":1783182086365,"version":"3.54.6"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cca.2026.121019","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:56:15Z","timestamp":1776696975000},"page":"121019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ISG15 as a novel serum biomarker for breast Cancer: Diagnostic and prognostic significance, clinical laboratory applications, and multi-biomarker integration strategies"],"prefix":"10.1016","volume":"589","author":[{"given":"Shakilur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Zharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadiah","family":"Alfakeeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid Swerah","family":"Al-Blwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh M.","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanad Maqbool","family":"Al-Osaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Essa","family":"Moafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shady A.","family":"Alghazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121019_bb0005","author":"World Health Organization, Breast cancer"},{"key":"10.1016\/j.cca.2026.121019_bb0010","article-title":"Breast cancer screening, IARC Handb","volume":"15","author":"International Agency for Research on Cancer","year":"2016","journal-title":"Cancer Prev."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41523-023-00506-5","article-title":"The central role of pathology labs in breast cancer precision oncology: a call for action","volume":"9","author":"Pruneri","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.cca.2026.121019_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100299","article-title":"The impact of liquid biopsy in breast cancer: redefining the landscape of non-invasive precision oncology","volume":"8","author":"Malik","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227356","article-title":"An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies","volume":"15","author":"Perrier","year":"2020","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s40001-025-03003-6","article-title":"Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives","volume":"30","author":"Zafar","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2010.0110","article-title":"Interferon-stimulated gene 15 and the protein ISGylation system","volume":"31","author":"Zhang","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00018-025-05705-w","article-title":"ISG-15, beyond its functions in the cell: a mini review","volume":"82","author":"Ali","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0045","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/1078-0432.CCR-11-2204","article-title":"Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy","volume":"18","author":"Hewitt","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00018-025-05849-9","article-title":"ISG15 modulates inflammatory profiles and ability to activate CD8+T cells in bone marrow-derived dendritic cells","volume":"82","author":"Mart\u00ednez-Fleta","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.cca.2026.121019_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-020-05955-1","article-title":"The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer","volume":"185","author":"Kariri","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"41","key":"10.1016\/j.cca.2026.121019_bb0060","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1038\/onc.2011.574","article-title":"N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer","volume":"31","author":"Su","year":"2012","journal-title":"Oncogene"},{"issue":"43","key":"10.1016\/j.cca.2026.121019_bb0065","doi-asserted-by":"crossref","first-page":"70143","DOI":"10.18632\/oncotarget.12160","article-title":"Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-\u03baB signaling pathway","volume":"7","author":"Mao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.121019_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1732718","article-title":"Macrophage polarization: molecular mechanisms, disease implications, and targeted therapeutic strategies","volume":"16","author":"Ji","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0075","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.18632\/oncotarget.3372","article-title":"Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective","volume":"6","author":"Burks","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0080","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1158\/0008-5472.CAN-15-1795","article-title":"Intracellular released payload influences potency and bystander-killing effects of antibody-drug conjugates in preclinical models","volume":"76","author":"Li","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0085","first-page":"371","article-title":"USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT\/Skp2 pathway","volume":"53","author":"Tan","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/2159-8290.CD-19-0608","article-title":"Type i interferon regulates a coordinated gene network to enhance cytotoxic t cell-mediated tumor killing","volume":"10","author":"Fan","year":"2020","journal-title":"Cancer Discov."},{"issue":"14","key":"10.1016\/j.cca.2026.121019_bb0095","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/febs.16768","article-title":"MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy","volume":"290","author":"Zhou","year":"2023","journal-title":"FEBS J."},{"issue":"44","key":"10.1016\/j.cca.2026.121019_bb0100","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1038\/s41388-021-02017-8","article-title":"ISGylation drives basal breast tumour progression by promoting EGFR recycling and akt signalling","volume":"40","author":"Bolado-Carrancio","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2026.121019_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120692","article-title":"HERC5\/IFI16\/p53 signaling mediates breast cancer cell proliferation and migration","volume":"303","author":"Liu","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0110","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1038\/ncomms13588","article-title":"ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins","volume":"7","author":"Villarroya-Beltri","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2017.10.003","article-title":"Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor","volume":"68","author":"Swaim","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/pathogens15010122","article-title":"Extracellular lipopolysaccharide triggers the release of unconjugated interferon-stimulated gene 15 (ISG15) protein from macrophages via type-I interferon\/caspase-4\/gasdermin-D pathway","volume":"15","author":"Pandit","year":"2026","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1074\/mcp.M900398-MCP200","article-title":"Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas","volume":"9","author":"Wu","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yexcr.2018.03.017","article-title":"ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET\/Fyn\/\u03b2-catenin signaling pathway","volume":"367","author":"Yuan","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0135","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1038\/s41467-020-16395-2","article-title":"ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity","volume":"11","author":"Alcal\u00e1","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cca.2026.121019_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jex2.92","article-title":"ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis","volume":"3","author":"Dorayappan","year":"2024","journal-title":"J. Extracell. Biol."},{"issue":"8","key":"10.1016\/j.cca.2026.121019_bb0145","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1021\/acs.jproteome.3c00761","article-title":"Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets","volume":"23","author":"Hagn","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.121019_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-12-9","article-title":"Comparison of serum, EDTA plasma and p100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study","volume":"12","author":"O'Neal","year":"2014","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.121019_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040964","article-title":"MicroRNA-101-3p suppresses cancer cell growth by inhibiting the USP47-induced deubiquitination of RPL11","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121019_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-10-52","article-title":"Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays","volume":"10","author":"de Jager","year":"2009","journal-title":"BMC Immunol."},{"issue":"2\u20133","key":"10.1016\/j.cca.2026.121019_bb0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-014-8491-6","article-title":"Effects of serum and plasma matrices on multiplex immunoassays","volume":"58","author":"Rosenberg-Hasson","year":"2014","journal-title":"Immunol. Res."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrp.2015.11.005","article-title":"Effect of repeated freezing and thawing on biomarker stability in plasma and serum samples","volume":"6","author":"Lee","year":"2015","journal-title":"Osong. Public Health Res. Perspect."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0175","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41598-018-21387-w","article-title":"Red blood cells are dynamic reservoirs of cytokines","volume":"8","author":"Karsten","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cca.2026.121019_bb0180","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/jalm\/jfaf085","article-title":"Assessment of impact of hemolysis in human and nonhuman serum specimens on multiplex cytokine quantification","volume":"10","author":"Thorn","year":"2025","journal-title":"J. Appl. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121019_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1373\/clinchem.2009.135087","article-title":"Comparison of multiplex immunoassay platforms","volume":"56","author":"Fu","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121019_bb0190","doi-asserted-by":"crossref","DOI":"10.3788\/COL202018.051701","article-title":"Detection of breast cancer based on novel porous silicon bragg reflector surface-enhanced raman spectroscopy-active structure","volume":"18","author":"Ma","year":"2020","journal-title":"Chin. Opt. Lett."},{"issue":"12","key":"10.1016\/j.cca.2026.121019_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.cca.2026.121019_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026332","article-title":"From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay","volume":"6","author":"Kraemer","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.cca.2026.121019_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.cca.2026.121019_bb0210","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1515\/cclm-2019-1145","article-title":"Interleukin-6 chemiluminescent immunoassay on lumipulse g600 II: analytical evaluation and comparison with three other laboratory analyzers","volume":"58","author":"Glady","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121019_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114224","article-title":"Performance of the roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms","volume":"296","author":"Lau","year":"2021","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.cca.2026.121019_bb0220","article-title":"Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: an italian real-life experience","volume":"39","author":"Romano","year":"2024","journal-title":"Pract. Lab. Med."},{"issue":"15","key":"10.1016\/j.cca.2026.121019_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clinbiochem.2014.07.012","article-title":"Redefining normal bone and mineral clinical biochemistry reference intervals for healthy infants in Canada","volume":"47","author":"Gallo","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121019_bb0230","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1087057110362099","article-title":"Quantitative validation and comparison of multiplex cytokine kits","volume":"15","author":"Richens","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.cca.2026.121019_bb0235","article-title":"Development and validation of an ultrasensitive single molecule array digital enzyme-linked immunosorbent assay for human interferon-\u03b1","volume":"136","author":"Llibre","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0240","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1373\/clinchem.2006.077776","article-title":"High-throughput microtiter well-based chemiluminometric genotyping of 15 HBB gene mutations in a dry-reagent format","volume":"53","author":"Glynou","year":"2007","journal-title":"Clin. Chem."},{"issue":"18","key":"10.1016\/j.cca.2026.121019_bb0245","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.clinbiochem.2010.09.010","article-title":"The relationship of lipid profile and menstrual cycle with acne vulgaris","volume":"43","author":"Kataria Arora","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121019_bb0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2018.02.006","article-title":"Serum and dietary zinc and copper in iranian girls","volume":"54","author":"Gonoodi","year":"2018","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.cca.2026.121019_bb0255","article-title":"Cardiovascular risk stratification in diabetic retinopathy via atherosclerotic pathway in COVID-19\/non-COVID-19 frameworks using artificial intelligence paradigm: A Narrative Rev.","volume":"12","author":"Munjral","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121019_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04454-4","article-title":"ISG15 as a prognostic biomarker in solitary fibrous tumour","volume":"79","author":"Mondaza Hernandez","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cca.2026.121019_bb0265","article-title":"ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia","volume":"15","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031337","article-title":"The functional roles of ISG15\/ISGylation in cancer","volume":"28","author":"Yuan","year":"2023","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.cca.2026.121019_bb0275","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.18632\/oncotarget.7626","article-title":"ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0280","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-07-2345","article-title":"ISG15 as a novel tumor biomarker for drug sensitivity","volume":"7","author":"Desai","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"47","key":"10.1016\/j.cca.2026.121019_bb0285","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.36922\/td.7107","article-title":"Cyclin-dependent kinase 4\/6 inhibitor resistance mechanisms and strategies for subsequent treatment in breast cancer: a comprehensive review","volume":"4","author":"Zhang","year":"2025","journal-title":"Tumor Discov."},{"key":"10.1016\/j.cca.2026.121019_bb0295","article-title":"Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis","volume":"15","author":"Sun","year":"2025","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.cca.2026.121019_bb0300","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/2326-6066.CIR-25-0047","article-title":"Chronic ISG15 exposure accelerates CD8+ t-cell dysfunction while increasing PD-1 blockade sensitivity in oral squamous cell carcinoma","volume":"13","author":"Chen","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"Pt 3","key":"10.1016\/j.cca.2026.121019_bb0305","article-title":"Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer","volume":"338","author":"Zhou","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0310","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40005-025-00731-z","article-title":"Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy","volume":"55","author":"Yuan","year":"2025","journal-title":"J. Pharm. Investig."},{"issue":"4","key":"10.1016\/j.cca.2026.121019_bb0315","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/bcr2117","article-title":"The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer","volume":"10","author":"Bektas","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"11","key":"10.1016\/j.cca.2026.121019_bb0320","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s12276-022-00872-3","article-title":"The diverse repertoire of ISG15: more intricate than initially thought","volume":"54","author":"Kang","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12916-025-04614-w","article-title":"ISG15-driven immune modulation and tumor progression in breast cancer metastasis: insights from single-cell and spatial transcriptomics","volume":"24","author":"Shao","year":"2026","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0330","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/srep02375","article-title":"Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121019_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5582151","article-title":"CD4(+)T and CD8(+)T cells in uterus exhibit both selective dysfunction and residency signatures","volume":"2024","author":"Kang","year":"2024","journal-title":"J. Immunol. Res."},{"issue":"7","key":"10.1016\/j.cca.2026.121019_bb0340","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ecco-jcc\/jjaa022","article-title":"Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and crohn's disease","volume":"14","author":"\u00d8stvik","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cca.2026.121019_bb0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellsig.2018.11.021","article-title":"Interplay between interferon-stimulated gene 15\/ISGylation and interferon gamma signaling in breast cancer cells","volume":"54","author":"Tecalco-Cruz","year":"2019","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.cca.2026.121019_bb0350","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00262-025-04026-y","article-title":"Cohort-based pan-cancer analysis and experimental studies reveal ISG15 gene as a novel biomarker for prognosis and immunotherapy efficacy prediction","volume":"74","author":"Wei","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.cca.2026.121019_bb0355","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cca.2010.02.051","article-title":"Discordance in PON1 and PON2 single nucleotide polymorphism determinations between the fully automated sequenom MALDI-TOF MS MassEXTEND\u2122 and manual MS\u2013PCR assays","volume":"411","author":"Chan","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.36922\/td.4093","article-title":"Efficacy of pyrotinib and capecitabine in recurrent breast cancer with a HER2-negative genetic switch following systemic therapy: a case report and literature review","volume":"4","author":"Zhang","year":"2025","journal-title":"Tumor Discov."},{"issue":"11","key":"10.1016\/j.cca.2026.121019_bb0365","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cca.2011.01.018","article-title":"Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations","volume":"412","author":"Lippi","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121019_bb0370","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2015.09.004","article-title":"Cancer screening through a multi-analyte serum biomarker panel during health check-up examinations: results from a 12-year experience","volume":"450","author":"Wen","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"6378","key":"10.1016\/j.cca.2026.121019_bb0375","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"Suppl. 18","key":"10.1016\/j.cca.2026.121019_bb0380","doi-asserted-by":"crossref","first-page":"S2165","DOI":"10.21037\/jtd.2018.06.58","article-title":"Multi-analyte assays and early detection of common cancers","volume":"10","author":"Young","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.cca.2026.121019_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102041","article-title":"A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study","volume":"61","author":"Luan","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0390","article-title":"Novel proteomics-based plasma test for early detection of multiple cancers in the general population","volume":"3","author":"Budnik","year":"2024","journal-title":"BMJ Oncol."},{"issue":"4","key":"10.1016\/j.cca.2026.121019_bb0395","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2018.04.030","article-title":"Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells","volume":"499","author":"Tecalco-Cruz","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.cca.2026.121019_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70470","article-title":"The analysis of plasma proteomics for luminal a breast cancer","volume":"13","author":"Zhao","year":"2024","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0405","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","article-title":"FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li","year":"2021","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"7","key":"10.1016\/j.cca.2026.121019_bb0410","first-page":"854","article-title":"High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer","volume":"22","author":"Xiao","year":"2025","journal-title":"Cancer Biol. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0415","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf180","article-title":"A plasma-based deep proteomic platform for early-stage breast cancer detection","volume":"167","author":"Horrmann","year":"2026","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0420","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41467-020-15283-z","article-title":"Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors","volume":"11","author":"Djomehri","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.121019_bb0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2013.01.015","article-title":"Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with cytokeratin 19-derived CYFRA21-1 and pathological staging","volume":"419","author":"Chen","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121019_bb0430","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5746-6","article-title":"Evaluating diagnostic strategies for early detection of cancer: the CanTest framework","volume":"19","author":"Walter","year":"2019","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.cca.2026.121019_bb0435","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097591","article-title":"Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol","volume":"15","author":"Mulliqi","year":"2025","journal-title":"BMJ Open"},{"issue":"13","key":"10.1016\/j.cca.2026.121019_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133077","article-title":"Development of a multiprotein classifier for the detection of early stage ovarian cancer","volume":"14","author":"Boylan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0445","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.4049\/jimmunol.157.9.4100","article-title":"In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine","volume":"157","author":"D\u2019Cunha","year":"1996","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0450","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00228-020-02912-1","article-title":"Establishment of reference intervals of biochemical analytes for healthy chinese volunteers during the screening process in clinical pharmacology trials","volume":"76","author":"Zhong","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0455","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/10408363.2018.1482256","article-title":"Distinguishing reference intervals and clinical decision limits - a review by the IFCC committee on reference intervals and decision limits","volume":"55","author":"Ozarda","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2026.121019_bb0460","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.3389\/bjbs.2024.12339","article-title":"The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection","volume":"81","author":"Timbrell","year":"2024","journal-title":"Br. J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.121019_bb0465","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/clinchem\/hvae129","article-title":"Clinical decision-making suffers from inequivalent measurement results and inadequate reference intervals","volume":"70","author":"van Schrojenstein Lantman","year":"2024","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2026.121019_bb0470","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1515\/cclm-2024-0696","article-title":"External quality assessment-based tumor marker harmonization simulation; insights in achievable harmonization for CA 15-3 and CEA","volume":"63","author":"Van Rossum","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.121019_bb0475","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3343\/alm.2024.0082","article-title":"Quantitative evaluation of the real-world harmonization status of laboratory test items using external quality assessment data","volume":"44","author":"Kim","year":"2024","journal-title":"Ann. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.121019_bb0480","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1515\/cclm-2024-1291","article-title":"Behind the scenes of EQA \u2013 characteristics, capabilities, benefits and assets of external quality assessment (EQA): part III \u2013 EQA samples","volume":"63","author":"Buchta","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.121019_bb0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40629-024-00312-w","article-title":"Requirements for regulatory acceptance of biomarkers","volume":"33","author":"Zander","year":"2024","journal-title":"Allergo J. Int."},{"issue":"5","key":"10.1016\/j.cca.2026.121019_bb0490","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.CCR-24-2729","article-title":"Challenges to innovation arising from current companion diagnostic regulations and suggestions for improvements","volume":"31","author":"Oliner","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0495","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/1055-9965.EPI-23-1594","article-title":"Designing rigorous and efficient clinical utility studies for early detection biomarkers","volume":"33","author":"Zheng","year":"2024","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0500","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41698-025-01019-z","article-title":"Association of circulating immuno-oncology biomarkers with breast cancer risk: insights from two prospective cohorts","volume":"9","author":"Zheng","year":"2025","journal-title":"NPJ Precis. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2026.121019_bb0505","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41416-023-02541-2","article-title":"The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk","volume":"130","author":"Grassmann","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.cca.2026.121019_bb0510","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1158\/0008-5472.CAN-23-3998","article-title":"Proteomic profiling of serum extracellular vesicles identifies diagnostic signatures and therapeutic targets in breast cancer","volume":"84","author":"Xu","year":"2024","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cca.2026.121019_bb0515","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/00045632241307186","article-title":"Exploratory study on reference intervals of calprotectin and pentraxin 3","volume":"62","author":"Alfirevic","year":"2025","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3343\/alm.2025.0027","article-title":"A machine learning approach to reference interval estimation for red cell parameters in a south and east asian population","volume":"46","author":"Nadarajan","year":"2026","journal-title":"Ann. Lab. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121019_bb0525","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.20892\/j.issn.2095-3941.2020.0516","article-title":"Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma","volume":"19","author":"Zuo","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3343\/alm.2024.44.1.6","article-title":"Bias in laboratory medicine: the dark side of the moon","volume":"44","author":"Coskun","year":"2024","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cca.2026.121019_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2025.110654","article-title":"Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type i interferon response","volume":"283","author":"Michiels","year":"2026","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2026.121019_bb0540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.21037\/jlpm.2017.12.01","article-title":"Integration of ISO 15189 and external quality assurance data to assist the detection of poor laboratory performance in NSW, Australia","volume":"2","author":"Lidbury","year":"2017","journal-title":"J. Lab. Precis. Med."},{"key":"10.1016\/j.cca.2026.121019_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1401619","article-title":"Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125","volume":"11","author":"Kremser","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.cca.2026.121019_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105909","article-title":"Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the european union-a comparative overview","volume":"10","author":"Kahles","year":"2025","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.cca.2026.121019_bb0555","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1021\/acs.jproteome.5c00571","article-title":"Brief evaluation of olink reveal proximity extension assay for high-throughput proteomics: a case study using NIST SRM 1950 and two spike-in protein standards","volume":"24","author":"van der Burgt","year":"2025","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.cca.2026.121019_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110564","article-title":"Identification and characterization of nanobodies specific for the human ubiquitin\u2013like ISG15 protein","volume":"301","author":"Gan","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2026.121019_bb0565","doi-asserted-by":"crossref","first-page":"12122","DOI":"10.1038\/s41598-025-95232-2","article-title":"Distinct proteomic profiles of plasma-derived extracellular vesicles in healthy, benign, and triple-negative breast cancer: candidate biomarkers for liquid biopsy","volume":"15","author":"Tamarindo","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:58:18Z","timestamp":1783180698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":113,"alternative-id":["S0009898126002019"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121019","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ISG15 as a novel serum biomarker for breast Cancer: Diagnostic and prognostic significance, clinical laboratory applications, and multi-biomarker integration strategies","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121019"}}